Show simple item record

Major histocompatibility complex class II (MHCII) and its transcriptional regulator, CIITA, are aberrantly expressed in discrete beta cells in individuals with Type 1 diabetes

dc.contributor.authorRussell, MA
dc.contributor.authorFoulis, AK
dc.contributor.authorKrogvold, L
dc.contributor.authorDahl-Jorgensen, K
dc.contributor.authorRichardson, SJ
dc.contributor.authorMorgan, NG
dc.date.accessioned2017-07-27T12:58:08Z
dc.date.issued2017-03
dc.description.abstractDiabetes UK Professional Conference Abstracten_GB
dc.identifier.citationVol. 34, supplement S1, p. 40, abstract P13en_GB
dc.identifier.urihttp://hdl.handle.net/10871/28668
dc.language.isoenen_GB
dc.publisherWiley for Diabetes UKen_GB
dc.rights.embargoreasonPublisher policyen_GB
dc.rights© 2017 The Authors, presented at the Diabetes UK Professional Conference. © 2017 Diabetes UK.en_GB
dc.titleMajor histocompatibility complex class II (MHCII) and its transcriptional regulator, CIITA, are aberrantly expressed in discrete beta cells in individuals with Type 1 diabetesen_GB
dc.identifier.issn0742-3071
pubs.declined2017-07-27T11:46:11.610+0100
dc.descriptionThis is the author accepted manuscript. The final version is available from Wiley via the DOI in this record.en_GB
dc.descriptionSpecial Issue of Diabetic Medicine: Abstracts of the Diabetes UK Professional Conference 2017, Manchester Central, Manchester, 8–10 March 2017en_GB
dc.identifier.journalDiabetic Medicineen_GB


Files in this item

Name:
Diabetic Medicine 2017 Russell ...
Size:
12.43Kb
Format:
Microsoft Word 2007
View/Open

This item appears in the following Collection(s)

Show simple item record